Boyd Peter E.

Insider CIK 1739816 · AQST See Remarks

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
AQST Aquestive Therapeutics, In	X Exercise deriv	2026-09-09	2026-09-10	2,293	—	$0	0	SEC↗
AQST Aquestive Therapeutics, In	X Exercise	2026-09-09	2026-09-10	2,293	$0.96	$2.2K	284,024	SEC↗
AQST Aquestive Therapeutics, In	X Exercise deriv	2026-09-09	2026-09-10	2,293	—	$0	0	SEC↗
AQST Aquestive Therapeutics, In	X Exercise	2026-09-09	2026-09-10	2,293	$0.96	$2.2K	284,024	SEC↗
AQST Aquestive Therapeutics, In	F Tax w/h	2026-05-05	2026-05-07	56,778	$4.18	$237.3K	281,731	SEC↗
AQST Aquestive Therapeutics, In	S Sale	2026-03-10	2026-03-11	29,814	$4.17	$124.3K	338,509	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2026-03-09	2026-03-11	42,500	$4.29	$182.3K	42,500	SEC↗
AQST Aquestive Therapeutics, In	A Award	2026-03-09	2026-03-11	80,000	—	$0	368,323	SEC↗
AQST Aquestive Therapeutics, In	A Award	2025-12-04	2025-12-05	20,000	—	$0	288,323	SEC↗
AQST Aquestive Therapeutics, In	S Sale	2025-10-15	2025-10-17	10,000	$7.00	$70.0K	268,323	SEC↗
AQST Aquestive Therapeutics, In	S Sale	2025-09-26	2025-09-29	10,000	$6.30	$63.0K	278,323	SEC↗
AQST Aquestive Therapeutics, In	S Sale	2025-09-05	2025-09-08	15,000	$5.30	$79.5K	288,323	SEC↗
AQST Aquestive Therapeutics, In	F Tax w/h	2025-03-09	2025-03-11	7,681	$2.65	$20.4K	303,323	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2025-03-07	2026-04-13	60,000	—	$0	60,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2025-03-07	2025-03-11	40,000	—	$0	40,000	SEC↗
AQST Aquestive Therapeutics, In	A Award	2025-03-07	2025-03-11	80,000	—	$0	317,628	SEC↗
AQST Aquestive Therapeutics, In	F Tax w/h	2025-03-07	2025-03-11	6,624	$2.65	$17.6K	311,004	SEC↗
AQST Aquestive Therapeutics, In	F Tax w/h	2024-03-09	2024-03-12	8,370	$4.88	$40.8K	237,628	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2024-03-07	2024-03-11	43,125	—	$0	43,125	SEC↗
AQST Aquestive Therapeutics, In	A Award	2024-03-07	2024-03-11	86,250	—	$0	245,998	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2023-08-09	2023-08-09	50,000	—	$0	50,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2023-05-05	2023-05-05	50,000	—	$0	50,000	SEC↗
AQST Aquestive Therapeutics, In	A Award	2023-03-09	2023-03-09	100,000	—	$0	159,532	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2022-11-04	2022-11-08	25,000	—	$0	25,000	SEC↗
AQST Aquestive Therapeutics, In	P Buy	2022-06-14	2022-06-15	5,000	$0.81	$4.1K	59,532	SEC↗
AQST Aquestive Therapeutics, In	P Buy deriv	2022-06-08	2022-06-10	2,293	$0.13	$298	2,293	SEC↗
AQST Aquestive Therapeutics, In	P Buy	2022-06-08	2022-06-10	2,293	$0.96	$2.2K	54,532	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2022-03-10	2022-03-14	70,000	—	$0	70,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2021-03-11	2021-03-15	35,000	—	$0	35,000	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2020-03-16	2020-03-18	50,700	—	$0	50,700	SEC↗
AQST Aquestive Therapeutics, In	P Buy	2020-03-16	2020-03-18	2,000	$1.50	$3.0K	52,239	SEC↗
AQST Aquestive Therapeutics, In	P Buy	2019-08-12	2019-08-13	600	$3.81	$2.3K	50,239	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2019-02-28	2019-03-04	30,000	—	$0	30,000	SEC↗
AQST Aquestive Therapeutics, In	P Buy	2018-11-21	2018-11-26	200	$9.98	$2.0K	49,639	SEC↗
AQST Aquestive Therapeutics, In	A Award deriv	2018-07-24	2018-07-26	36,223	—	$0	36,223	SEC↗